Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Tyler Schuster is an ag industry advocate who mentors and supports the next generation, especially women finding their place in the cattle industry.
NCBA Chief Counsel Mary-Thomas Hart breaks down CAFO permits, EPA enforcement, and what cattle producers need to know as rules continue to evolve.
Rebuilding domestic textiles depends on automation and vertical integration, not tariffs or legacy manufacturing models.
RFD NEWS correspondent Frank McCaffrey spoke with U.S. Congressmen Henry Cuellar (D-TX) and John Rose (R-TN), who say bipartisan cooperation will be key to getting the Farm Bill to the president’s desk.
The EPA has approved over-the-top dicamba applications for the 2026 and 2027 growing seasons, outlining new rules that impact herbicide use for U.S. crop producers.
Top issues facing the beef industry took center stage at CattleCon this year in Nashville.